Opportunity to Address a Wide Range of Immunology Indications
Orals with Biologics-Like Activity to Transform Immunology

                         Dermatology                       Respiratory               GI                    Rheumatology                                  Other
                                                                                                                                               (Neuro, Endocrinology, Heme)

  Immune
 Classes &    AD   HS   CSU   PN   BP   Vitiligo   AA   Asthma   COPD CRSwNP   IBD        EoE   RA   SLE     SSc   Sjögren’s   DM   Myositis   MG     CIDP     GD      ITP
Indications

STAT6
KT-621

 IRF5
KT-579

 IRAK4
KT-4851
Upcoming
Novel Oral
Programs


       Synergies and know-how across key immunological pathways creates multiple development and combination
       opportunities and positions Kymera to expand access to systemic advanced therapies for broad patient populations



                                                                                                                                                                              10
